Going concern is a standard test on any entity at year end.
if you have no revenue with the exception of your R&D tax credit, your always reliant on funding. The auditors have no idea about funding or the success of any capital raising. All they can really say is the runway ends at point x without any funding.
This is the biotech world. Look at your assets, if you have a quality asset with potential you will always get funding.
scare mongering. IMO
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia completes recruitment to Cantrixil Phase 1 trial
Ann: Kazia completes recruitment to Cantrixil Phase 1 trial, page-59
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online